Staar Surgical Co (STAA)
48.19
+1.64
(+3.52%)
USD |
NASDAQ |
Apr 23, 16:00
48.26
+0.07
(+0.15%)
After-Hours: 20:00
Staar Surgical Research and Development Expense (Quarterly): 10.87M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.87M |
| September 30, 2023 | 11.47M |
| June 30, 2023 | 11.76M |
| March 31, 2023 | 10.31M |
| December 31, 2022 | 9.79M |
| September 30, 2022 | 9.616M |
| June 30, 2022 | 8.636M |
| March 31, 2022 | 7.941M |
| December 31, 2021 | 9.072M |
| September 30, 2021 | 8.271M |
| June 30, 2021 | 8.26M |
| March 31, 2021 | 8.259M |
| December 31, 2020 | 8.958M |
| September 30, 2020 | 8.751M |
| June 30, 2020 | 7.311M |
| March 31, 2020 | 6.898M |
| December 31, 2019 | 7.409M |
| September 30, 2019 | 6.156M |
| June 30, 2019 | 6.098M |
| March 31, 2019 | 5.635M |
| December 31, 2018 | 5.705M |
| September 30, 2018 | 5.57M |
| June 30, 2018 | 5.346M |
| March 31, 2018 | 5.407M |
| December 31, 2017 | 5.626M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.594M |
| June 30, 2017 | 4.767M |
| March 31, 2017 | 4.783M |
| December 31, 2016 | 4.65M |
| September 30, 2016 | 4.453M |
| June 30, 2016 | 4.659M |
| March 31, 2016 | 6.906M |
| December 31, 2015 | 3.961M |
| September 30, 2015 | 3.684M |
| June 30, 2015 | 3.536M |
| March 31, 2015 | 3.579M |
| December 31, 2014 | 5.643M |
| September 30, 2014 | 3.137M |
| June 30, 2014 | 2.498M |
| March 31, 2014 | 3.484M |
| December 31, 2013 | 1.972M |
| September 30, 2013 | 1.684M |
| June 30, 2013 | 1.686M |
| March 31, 2013 | 1.366M |
| December 31, 2012 | 1.804M |
| September 30, 2012 | 1.582M |
| June 30, 2012 | 1.513M |
| March 31, 2012 | 1.546M |
| December 31, 2011 | 1.589M |
| September 30, 2011 | 1.454M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
6.098M
Minimum
Jun 2019
11.76M
Maximum
Jun 2023
8.728M
Average
8.636M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Anika Therapeutics Inc | 7.585M |
| The Cooper Companies Inc | 39.50M |
| OrthoPediatrics Corp | 2.747M |
| NexGel Inc | 0.013M |
| Innovative Eyewear Inc | 0.1208M |